Nonclinical Pharmacology/Toxicology Development of Topical Drugs Intended to Prevent the Transmission of Sexually Transmitted Diseases (STD) and/or for the Development of Drugs Intended to Act as Vaginal Contraceptives
Detailed guidance document from FDA and regulatory agencies.
Document Details
Unknown
June 30, 2005
Center for Drug Evaluation and Research
677f9203-5a06-45ca-b98b-cd4d306cc844
Related Documents
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.